

ICYMI: BMC Ingredients sets out the evidence behind Rhiza’s healthy-aging potential
BMC Ingredients is investigating the healthy-aging potential of bioactive compounds naturally present in its Rhiza mycelium, while stressing that research identifying those compounds has not established a human health benefit from consuming them in the ingredient.
• Rhiza contains naturally occurring ergothioneine and spermidine.
• Ingredient-specific human health benefits remain to be established.
• BMC discusses familiar foods combining protein, fiber and functionality.
“We’re really in the early stages of the journey,” says Madeleine McDougall, Vice President of Business Development at BMC Ingredients, discussing the work during PPTI’s November 12 webinar, Designing Foods for Healthy Aging: The Next Generation of Nutrition, in partnership with HGF.
McDougall describes ergothioneine and spermidine as promising areas of research, supported by evidence that includes observational human studies and animal work. She cautions that their evidence base is less established than the relationships between protein, fiber and healthy aging.
The company’s recent peer-reviewed paper examined the presence of the compounds in its Neurospora crassa mycelium. McDougall says that analysis provides a foundation for further research, rather than proof of effects on human aging.
“We do not fortify Rhiza with these compounds,” she says. “In fact, it was really a happy accident that we discovered their presence in the first place.”
She describes spermidine as a naturally occurring polyamine associated with autophagy, the process through which cells recycle components, and ergothioneine as an antioxidant attracting interest in aging research. The webinar does not present a clinical trial demonstrating benefits from either compound in Rhiza.
For BMC, the compounds add to a nutritional profile that already includes protein, fiber and micronutrients. McDougall says the ingredient contains 51% protein and has a complete amino acid profile. She also identifies iron, zinc and potassium among its nutritional components.
Her emphasis is on the combination available within a whole-food mycelium ingredient. BMC is seeking applications in which that composition can help manufacturers improve nutritional density while retaining the characteristics people enjoy in an existing food.

The approach is relevant to older consumers whose appetites may be smaller, McDougall says. If someone eats less, the composition of each serving becomes more important, and a protein target alone will not account for all the nutrients the product could provide.
“Consumers shouldn’t have to sacrifice taste or price to get the nutrition that they need,” she says.
One example is hybrid meat. McDougall says manufacturers can blend animal meat with up to 40% Rhiza mycelium, with the aim of retaining protein and eating quality while adding fiber and reducing saturated fat, cholesterol and sodium. The resulting nutritional profile depends on the formulation.
She sees value in improving foods people already recognize, particularly when developing for older consumers who may be less interested in unfamiliar foods or flavors. The application work therefore involves both the ingredient’s nutrient contribution and its effect on texture and other functional requirements.
BMC offers two formats for different uses. Rhiza Tex is a dehydrated textured ingredient for applications including meat and seafood products. Rhiza Pro is a powder intended for foods such as nutritional beverages, pasta, baked goods, bars and soups.
McDougall says those formats expand the number of products in which manufacturers can use the mycelium. Their suitability depends on what the food needs to do as well as what it contains; a nutritional beverage and a textured meat product require different physical properties.
HGF Patent Director Andrew Tindall also addresses the evidence needed when companies investigate new health applications. Long-term outcomes can take many years to assess, he says, but developers may be able to measure narrower effects in earlier experiments and consider what those results could support in a patent application.
That patent discussion is separate from establishing a consumer health benefit. McDougall’s account of BMC’s work identifies the presence of compounds in its ingredient, with further research needed to determine their effects when consumed in that form.
Asked what developers should establish before starting a healthy-aging project, she recommends considering nutrient density and functionality together. “Importantly, asking, can I use this to make a delicious, nutrient-dense product?” she says.
Watch Designing Foods for Healthy Aging: The Next Generation of Nutrition
If you liked this, check these out...
• BMC Ingredients study finds ergothioneine and spermidine in Rhiza mycelium
• The Better Meat Co becomes BMC Ingredients in strategic shift beyond meat alternatives
• Meala enables next-gen GLP-1–aligned food design, addressing the biggest formulation challenge of the GLP-1 era
If you have any questions or would like to get in touch with us, please email info@futureofproteinproduction.com
Heading
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.
More News
SIGN-UP TO OUR NEWSLETTER
View the full newsletter archive at Here




_main.jpg)


